Transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: A systematic review

BACKGROUND/AIMS: Transjugular intrahepatic portosystemic shunts (TIPS) in patients with hepatocellular carcinoma (HCC) may improve access to curative therapies, treat portal hypertension (PH)‐related complications without worsening liver function, and increase overall survival. Data on the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Norero, Blanca, Bosch, Jaume, Berzigotti, Annalisa, Rodrigues, Susana G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576600/
https://www.ncbi.nlm.nih.gov/pubmed/37736854
http://dx.doi.org/10.1002/ueg2.12454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576600/
https://www.ncbi.nlm.nih.gov/pubmed/37736854
http://dx.doi.org/10.1002/ueg2.12454

Ejemplares similares